首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1533641

流式細胞技術市場規模、佔有率和成長分析：按技術、產品/服務、應用和地區分類 - 產業預測，2024-2031

Flow Cytometry Market Size, Share, Growth Analysis, By Technology (Cell-Based, Bead-Based), Product & Service (Instruments, Software), Application (Research, Immunology), By Region - Industry Forecast 2024-2031

出版日期: 2024年08月06日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球流式細胞技術市場規模將為39.7億美元，從2023年的42.5億美元成長到2031年的69.9億美元，並將從2023年的42.5億美元成長到2031年的69.9億美元。 2031 年複合年成長率為7.17%）。

該行業的成長是由於癌症、免疫系統疾病和感染疾病發病率的增加。生物技術、生命科學和生物製藥領域研發支出的增加推動了對流式細胞技術設備的高需求。用於照護現場(POC) 測試的微流體流式細胞技術等創新體現了此技術的進步。 COVID-19大流行進一步推動了流式細胞技術的使用。流式細胞技術提高了準確性並能夠同時分析多個檢體，為目前 PCR 和基於抗體的測試方法提供了可行的替代方案。因此，流式細胞技術在 COVID-19 診斷和監測中的應用正在促進該領域的發展。該領域新產品的到來凸顯了儘管疫情大流行，但目前正在進行的創新。流式細胞技術提供了有關患者對 COVID-19 抗原反應的重要見解，並有助於有效的管理決策。此類技術創新的採用預計將在未來幾年推動該行業的成長。此外，全球感染疾病率的上升刺激了流式細胞技術技術的採用。這些技術對於尋找免疫表現型分析和細胞分離的替代方法來對抗每年奪走超過 450 萬人生命的疾病至關重要。流式細胞技術可以檢測環境樣本中的病原微生物，已成為免疫表現型分析的有效方法。

市場概況
研究用途
- 製藥/生物技術
- 藥物發現
- 幹細胞研究
- 試管內毒性試驗
免疫學
- 細胞分選
- 細胞凋亡
- 細胞週期分析
- 細胞活力
- 細胞計數
- 其他研究用途
臨床應用
- 癌症診斷
- 血液學
- 自體免疫疾病
- 器官移植
- 其他臨床應用
工業用途

流式細胞技術市場：依最終用戶分類

市場概況
學術/研究機構
醫院/臨床實驗室
製藥和生物技術公司

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Becton, Dickinson, and Company（US）
Danaher Corporation（US）
Thermo Fisher Scientific, Inc.（US）
Agilent Technologies, Inc.（US）
Sony Group Corporation（Japan）
Bio-Rad Laboratories, Inc.（US）
Miltenyi Biotec GmbH（Germany）
Enzo Biochem, Inc.（US）
Sysmex Corporation（Japan）
BioMerieux SA（France）
Cytonome/ST, LLC（US）
Cytek Biosciences, Inc.（US）
Union Biometrica, Inc.（US）
Fluxion Biosciences, Inc.（US）
Apogee Flow Systems Ltd.（UK）
Merck KGaA（Germany）

簡介目錄

Product Code: SQMIG35H2031

Global Flow Cytometry Market size was valued at USD 3.97 billion in 2022 and is poised to grow from USD 4.25 billion in 2023 to USD 6.99 billion by 2031, growing at a CAGR of 7.17% in the forecast period (2024-2031).

The growth of the industry is attributed to the increasing incidence of cancer, immune system disorders, and infections. The high demand for flow cytometry instruments is driven by increased spending on R&D in the biotechnology, life sciences, and biopharmaceutical sectors. Innovations like microfluidic flow cytometry for Point-of-Care (POC) testing exemplify the advancements in this technique. The COVID-19 pandemic has further propelled the use of flow cytometry. Its enhanced accuracy and ability to analyze multiple specimens simultaneously offer a viable alternative to current PCR- or antibody-based testing methods. Consequently, the application of flow cytometry in diagnosing and monitoring COVID-19 has contributed to the sector's growth. The emergence of new products in this field highlights ongoing innovations despite the pandemic. Flow cytometry provides crucial insights into a patient's response to COVID-19 antigens, aiding in effective management decisions. The adoption of such innovations is anticipated to drive industry growth in the future. Additionally, the rising incidence of infectious diseases worldwide has spurred the adoption of flow cytometry techniques. These techniques are essential for finding alternative methods for immunophenotyping and cell isolation to combat diseases that result in over 4.5 million fatalities annually. Flow cytometry can detect pathogenic microorganisms in environmental samples, making it a viable method for immunophenotyping.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Flow Cytometry market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Flow Cytometry Market Segmental Analysis

The flow cytometry market is segmented based on Technology, Product & Service, Application, End-use, and Region. Based on Technology, the market is segmented into Cell-Based Flow Cytometry, Bead-Based Flow Cytometry. Based on Product & Service, the market is segmented into Reagents & Consumables (Antibodies, Assays & Kits, Other Reagents & Consumables), Instruments (Cell Analyzers [High-range Cell Analyzers, Mid-range Cell Analyzers, Low-range Cell Analyzers], Cell Sorters [High-range Cell Sorters, Mid-range Cell Sorters, Low-range Cell Sorters]), Services, Software, Accessories. Based on Application, the market is segmented into Research Applications (Pharmaceutical & Biotechnology [Drug Discovery, Stem Cell Research, In Vitro Toxicity Testing]), Immunology (Cell Sorting, Apoptosis, Cell Cycle Analysis, Cell Viability, Cell Counting, Other Research Applications), Clinical Applications (Cancer Diagnostics, Hematology, Autoimmune Diseases, Organ Transplantation, Other Clinical Applications), and Industrial Applications. Based on End-user, the market is segmented into Academic & Research Institutes, Hospitals & Clinical Testing Laboratories, and Pharmaceutical & Biotechnology Companies. Based on region, the market is categorized into North America, Europe, Asia-Pacific, South America, and Middle East and Africa.

Drivers of the Global Flow Cytometry Market

Flow cytometry is essential for analyzing cell surface and intracellular molecules, characterizing diverse cell types, and assessing the purity of isolated subpopulations. The market is driven by increased R&D in multicolor assays and advanced reagents. The rising prevalence of chronic and infectious diseases, including COVID-19, has significantly boosted demand. Numerous research institutes and pharmaceutical companies are conducting extensive R&D to develop new vaccines and therapies, further fueling market growth.

Restraints in the Global Flow Cytometry Market

Flow cytometry instruments are expensive, making it difficult for many developing economies to afford technologically advanced models. These instruments typically cost between USD 75,000 and USD 100,000 for a four- to six-color, two-laser setup, creating a significant financial burden for small and medium-sized hospitals and diagnostic laboratories in these regions. For example, Thermo Fisher Scientific's Attune, a two-laser, six-color instrument, costs USD 99,000 in the United States. Consequently, the high cost of equipment is likely to limit the demand for advanced flow cytometers.

Market Trends of the Global Flow Cytometry Market

Flow cytometry is widely regarded as an excellent tool for characterizing, identifying, and isolating stem cells for both research and potential clinical applications. Recent advancements in flow cytometric hardware, reagents, and software have significantly enhanced the ability of stem cell biologists to identify and isolate rare cells. The extensive use of flow cytometry in disease diagnosis and early detection has further driven its adoption in stem cell research, thereby propelling the growth of the flow cytometry market.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Value Chain Analysis
Ecosystem of the Market
Start-up Analysis
Patent Analysis
Customer & Buying Criteria Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Market Attractive Index
Degree of Competition

Flow Cytometry Market by Technology

Market Overview
Cell-Based Flow Cytometry
Bead-Based Flow Cytometry

Flow Cytometry Market by Product & Service

Market Overview
Reagents & Consumables
- Antibodies
- Assays & Kits
- Other Reagents & Consumables
Instruments
- Cell Analysers
- High-range cell analysers
- Mid-range cell analysers
- Low-range cell analysers
- Cell Sorters
- High-range cell sorters
- Mid-range cell sorters
- Low-range cell sorters
Services
Software
Accessories

Flow Cytometry Market by Application

Market Overview
Research Applications
- Pharmaceutical & Biotechnology
- Drug discovery
- Stem cell research
- In vitro toxicity testing
Immunology
- Cell Sorting
- Apoptosis
- Cell Cycle Analysis
- Cell Viability
- Cell Counting
- Other Research Applications
Clinical Applications
- Cancer Diagnostics
- Hematology
- Autoimmune Diseases
- organ transplantation
- Other Clinical Applications
Industrial Applications

Flow Cytometry Market by End User

Market Overview
Academic & Research Institutes
Hospitals & Clinical Testing Laboratories
Pharmaceutical & Biotechnology Companies

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Becton, Dickinson, and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sony Group Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Miltenyi Biotec GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Enzo Biochem, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioMerieux S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cytonome/ ST, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cytek Biosciences, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Union Biometrica, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fluxion Biosciences, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
Apogee Flow Systems Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Beckman Coulter, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Stratedigm, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nanocellect Biomedical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments